The Role of Inflammation Markers in Occurrence of Radial Artery Occlusion

Overview

Journal Biomark Med

Specialties Biochemistry
General Medicine

Date 2024 Jul 23

PMID 39041846

Authors

Saadet Demirtas Inci

Huseyin Gunduz

Yasemin Gunduz

Affiliations

Soon will be listed here.

Abstract

Radial artery occlusion (RAO) is a major complication of catheterization via transradial access (TRA). Our aim is to reveal the ability of high-sensitive C-reactive protein (hs-CRP) and complete blood count (CBC) components, which are inflammation markers, to predict RAO. Patients were divided into two groups: 103 with RAO and 300 without RAO. The relationship between CRP, CBC components and RAO was evaluated. A significant increase in hs-CRP, monocyte, platelet (PLT), platelet distribution width (PDW) and plateletcrit values was observed after TRA, and only the increase in PDW, PLT and hs-CRP was found to be independent determinants in regression analysis. High PDW and PLT and increased hs-CRP levels are new independent determinants of the development of RAO.

References

Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopoulou F, Labrianou I . Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia. 2010; 14(1):28-32. PMC: 2843567. View

Clapp B, Hirschfield G, Storry C, Gallimore J, Stidwill R, Singer M . Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation. 2005; 111(12):1530-6. DOI: 10.1161/01.CIR.0000159336.31613.31. View

Rammos C, Burghardt A, Lortz J, Azizy O, Janosi R, Steinmetz M . Impact of anticoagulation and vasoactive medication on regained radial artery patency after catheterization: a case-control study. Eur J Med Res. 2018; 23(1):25. PMC: 5964909. DOI: 10.1186/s40001-018-0324-y. View

Cubero J, Lombardo J, Pedrosa C, Diaz-Bejarano D, Sanchez B, Fernandez V . Radial compression guided by mean artery pressure versus standard compression with a pneumatic device (RACOMAP). Catheter Cardiovasc Interv. 2009; 73(4):467-72. DOI: 10.1002/ccd.21900. View

Fay W . Linking inflammation and thrombosis: Role of C-reactive protein. World J Cardiol. 2010; 2(11):365-9. PMC: 3006472. DOI: 10.4330/wjc.v2.i11.365. View

Demirtas S, Karahan O, Yazici S, Guclu O, Caliskan A, Yavuz C . The relationship between complete blood count parameters and Fontaine's Stages in patients with peripheral arterial disease. Vascular. 2014; 22(6):427-31. DOI: 10.1177/1708538114522227. View

Mason P, Shah B, Tamis-Holland J, Bittl J, Cohen M, Safirstein J . An Update on Radial Artery Access and Best Practices for Transradial Coronary Angiography and Intervention in Acute Coronary Syndrome: A Scientific Statement From the American Heart Association. Circ Cardiovasc Interv. 2018; 11(9):e000035. DOI: 10.1161/HCV.0000000000000035. View

Monteiro Junior J, Torres D, da Silva M, Martins C, Silva I, do Nascimento M . Prognostic value of hematological parameters in patients with acute myocardial infarction: Intrahospital outcomes. PLoS One. 2018; 13(4):e0194897. PMC: 5905886. DOI: 10.1371/journal.pone.0194897. View

Wang R, Li Y, Zhu X, Zhang Y . Increased mean platelet volume is associated with arterial stiffness. Platelets. 2011; 22(6):447-51. DOI: 10.3109/09537104.2011.565431. View

10.

van der Bom J, Heckbert S, Lumley T, Holmes C, Cushman M, Folsom A . Platelet count and the risk for thrombosis and death in the elderly. J Thromb Haemost. 2009; 7(3):399-405. PMC: 2652240. DOI: 10.1111/j.1538-7836.2008.03267.x. View

11.

Ravkilde J, Nissen H, Mickley H, Andersen P, Thayssen P, Horder M . Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J. 1994; 127(1):13-20. DOI: 10.1016/0002-8703(94)90504-5. View

12.

Ashby B, Daniel J, Smith J . Mechanisms of platelet activation and inhibition. Hematol Oncol Clin North Am. 1990; 4(1):1-26. View

13.

Pancholy S . Transradial access in an occluded radial artery: new technique. J Invasive Cardiol. 2008; 19(12):541-4. View

14.

Pearson T, Mensah G, Alexander R, Anderson J, Cannon 3rd R, Criqui M . Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003; 107(3):499-511. DOI: 10.1161/01.cir.0000052939.59093.45. View

15.

Centemero M, Sousa A, Staico R, Abizaid A, Feres F, Tanajura L . [Comparative assessment of the prognostic value of four biochemical markers of myocardial damage after percutaneous coronary stenting]. Arq Bras Cardiol. 2004; 83 Spec No:53-8. DOI: /S0066-782X2004001900010. View

16.

Horne B, Anderson J, John J, Weaver A, Bair T, Jensen K . Which white blood cell subtypes predict increased cardiovascular risk?. J Am Coll Cardiol. 2005; 45(10):1638-43. DOI: 10.1016/j.jacc.2005.02.054. View

17.

Shah P . Circulating markers of inflammation for vascular risk prediction: are they ready for prime time. Circulation. 2000; 101(15):1758-9. DOI: 10.1161/01.cir.101.15.1758. View

18.

Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn P . Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 1991; 84(2):613-7. DOI: 10.1161/01.cir.84.2.613. View

19.

Meade T, Cooper J, Miller G . Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD). Thromb Haemost. 1997; 78(2):926-9. View

20.

Koupenova M, Clancy L, Corkrey H, Freedman J . Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis. Circ Res. 2018; 122(2):337-351. PMC: 5777300. DOI: 10.1161/CIRCRESAHA.117.310795. View